Latest news with #FAHA
Associated Press
2 days ago
- Health
- Associated Press
More than 150 hospitals nationwide recognized for comprehensive cardiovascular care
( NewMediaWire ) - July 29, 2025 - DALLAS — Heart disease and stroke are the No. 1 and No. 5 causes of death in the United States, respectively, according to the American Heart Association 2025 Statistical Update. Preventing cardiovascular deaths depends on a unified care approach rooted in evidence-based clinical treatments and collaboration. The American Heart Association, a global force changing the future of health for all, is recognizing 158 hospitals across the nation with a new Commitment to Quality award that highlights high performance across three or more clinical areas in the Get With The Guidelines(R) program. Hospitals earning this new award demonstrate a comprehensive approach to quality improvement for patient care. Get With The Guidelines programs help care teams use the latest evidence-based science to guide their treatment decisions. Studies show that following treatment guidelines can help people recover faster, avoid complications and reduce their chances of needing to return to the hospital. The programs are designed to ensure everyone gets care that's timely, consistent and backed by research. Get With The Guidelines awards are given for conditions including stroke, heart failure, heart attacks, cardiac arrest, Type 2 diabetes and atrial fibrillation. Award levels range from bronze to gold plus status, depending on how long and how well a care team meets key measures. Hospitals receiving the Commitment to Quality award have achieved Silver awards or higher in at least three American Heart Association programs for 2025. 'Delivering high-quality cardiovascular care requires a systemwide commitment to using proven treatments and putting patients at the center of every decision,' said Donald Lloyd-Jones, M.D., Sc.M., FAHA, past volunteer president of the American Heart Association and current volunteer chair of the Association's Quality Oversight Committee. 'Hospitals earning the Commitment to Quality award show what's possible when health care teams work together to apply the latest science across multiple areas of patient care. Their dedication is helping more people live longer, healthier lives.' Visit U.S. News & World Report to view the full list of recipients by state and award. Learn more about Get With The Guidelines at Additional Resources: ### About the American Heart Association The American Heart Association is a relentless force for a world of longer, healthier lives. Dedicated to ensuring equitable health in all communities, the organization has been a leading source of health information for more than one hundred years. Supported by more than 35 million volunteers globally, we fund groundbreaking research, advocate for the public's health, and provide critical resources to save and improve lives affected by cardiovascular disease and stroke. By driving breakthroughs and implementing proven solutions in science, policy, and care, we work tirelessly to advance health and transform lives every day. Connect with us on Facebook, X or by calling 1-800-AHA-USA1. About Get With The Guidelines Get With The Guidelines is a quality improvement program developed by the American Heart Association that connects hospitals with evidence-based guidelines to enhance patient care. It focuses on various conditions, including cardiovascular diseases and stroke, by promoting adherence to the latest scientific treatment guidelines. For more information, visit For Media Inquiries: Michelle Rosenfeld: [email protected] For Public Inquiries: 1-800-AHA-USA1 (242-8721) and
Associated Press
2 days ago
- Health
- Associated Press
Nearly 5,000 organizations nationwide recognized for high-quality cardiovascular care
( NewMediaWire ) - July 29, 2025 - DALLAS — Someone in the United States dies of cardiovascular disease (CVD) every 34 seconds, on average. [1] Reducing deaths from CVD requires a coordinated approach to care — one built on the transparent use of proven treatments and collaboration. The American Heart Association, devoted to changing the future to a world of healthier lives for all, is recognizing 4,859 health care and emergency response organizations nationwide for their continuing commitment to improving health outcomes for people affected by heart disease, stroke and related conditions. That's about 1,700 more organizations than were recognized last year, showing growing momentum in the effort to save lives. The recognition is tied to the American Heart Association's Get With The Guidelines(R) and other quality improvement initiatives that help care teams use the latest evidence-based science to guide their treatment decisions. The programs are designed to maximize opportunities for people to receive care that's timely, consistent and supported by research. The awards are given for conditions including stroke, heart failure, heart attacks, cardiac arrest, Type 2 diabetes and atrial fibrillation. Award levels range from bronze to gold plus, depending on how long and how well a hospital meets key measures. Among this year's awardees, the Association is recognizing 158 hospitals with a new Commitment to Quality award that highlights high performance across three or more clinical areas in the Get With The Guidelines program. Hospitals earning this new award demonstrate a comprehensive approach to quality improvement for patient care. 'When someone is having a heart attack or stroke, they need care that's fast, coordinated and follows the science,' said Donald Lloyd-Jones, M.D., Sc.M., FAHA, past volunteer president of the American Heart Association and current volunteer chair of the Association's Quality Oversight Committee. 'The organizations recognized this year are doing that work in communities all over the country — giving more people the best possible chance to live healthier, survive and recover.' This year, more than 14,500 total awards were given out, with many organizations receiving more than one. For the fifth year, the honorees represent all 50 states, Washington, D.C., Puerto Rico and Guam.* 'Health care teams continue to see the value of these programs,' Lloyd-Jones said. 'As the Association continues its second century of work, this kind of progress shows what we can achieve together to help people live longer, healthier lives.' Every 40 seconds, someone in the U.S. has a stroke or heart attack, and heart disease and stroke are the No. 1 and No. 5 causes of death in the United States, respectively, according to the American Heart Association 2025 Statistical Update. Studies show that following treatment guidelines can help patients recover faster, avoid complications and reduce their chances of needing to return to the hospital. Visit U.S. News & World Report to view the full list of recipients by state and award. Learn more about Get With The Guidelines at * Outpatient and EMS award numbers are not yet finalized; this is an approximation based on preliminary data. Additional Resources: ### About the American Heart Association The American Heart Association is a relentless force for a world of longer, healthier lives. Dedicated to ensuring equitable health in all communities, the organization has been a leading source of health information for more than one hundred years. Supported by more than 35 million volunteers globally, we fund groundbreaking research, advocate for the public's health, and provide critical resources to save and improve lives affected by cardiovascular disease and stroke. By driving breakthroughs and implementing proven solutions in science, policy, and care, we work tirelessly to advance health and transform lives every day. Connect with us on Facebook, X or by calling 1-800-AHA-USA1. About Get With The Guidelines Get With The Guidelines is a quality improvement program developed by the American Heart Association that connects hospitals with evidence-based guidelines to enhance patient care. It focuses on various conditions, including cardiovascular diseases and stroke, by promoting adherence to the latest scientific treatment guidelines. For more information, visit For Media Inquiries: Michelle Rosenfeld, 214-706-1099, [email protected] For Public Inquiries: 1-800-AHA-USA1 (242-8721) and [1] Martin S, et al. 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association. Table/chapter. Circulation. 2025;151(8):e41–e660.
Yahoo
16-07-2025
- Health
- Yahoo
Dr. Jennifer Ashton and Dr. Joseph Woo join American Heart Association Board of Directors
(NewMediaWire) - July 16, 2025 - DALLAS The American Heart Association, the world's leading nonprofit organization focused on heart and brain health for all, announces the appointment of two leading health and science leaders, Jennifer Ashton, M.D., M.S. and Joseph Woo, M.D., FAHA, to its volunteer Board of Directors, effective July 1, 2025. Dr. Ashton and Dr. Woo bring clinical leadership, health media influence and scientific innovation to the Association as it enters its second century, intensifying its efforts to change the future of health and improve cardiovascular and cerebrovascular health outcomes, which continue to be leading causes of death in the United States. Double board-certified in Ob-Gyn and obesity medicine, Dr. Jennifer Ashton is a nationally recognized women's health advocate known for communicating complex medical topics in an accessible way. As ABC News' Chief Medical Correspondent, she became a nationally trusted voice during major public health events, including the COVID-19 pandemic. A Columbia duPont and Emmy Award-winning journalist, a bestselling author and champion of preventive health and mental wellness, Dr. Ashton has volunteered with the American Heart Association for more than a decade, frequently speaking at local Go Red for Women(R) events. She has received numerous honors from the Association, including the 2024 Heart Saver Hero Award, the 2023 "Woman Changing the World Award" and the Go Red for Women Award in 2018. These accolades reflect her tireless advocacy for women's cardiovascular health and her leadership in advancing the Association's mission through education and action. "As the obesity and maternal mortality epidemics are two of the most pressing issues affecting women in the U.S., and since both have cardiovascular associations, I hope that my experience and expertise in these fields can assist the American Heart Association's efforts," Ashton said. "And, as the daughter of a cardiologist, I am honored to be the first OB-GYN appointed to the Board in the history of the Association." As a board-certified cardiothoracic surgeon, cardiovascular surgeon and transplant surgeon, Dr. Joseph Woo is a nationally recognized leader and educator in cardiac surgery innovation. He is professor and chair of the Stanford Medicine Department of Cardiothoracic Surgery, associate director of the Stanford Cardiovascular Institute and the Norman E. Shumway Professor of Cardiothoracic Surgery. He has pioneered advanced surgical research on multiple studies and clinical trials, including numerous National Institutes of Health (NIH) grant projects, as well as American Heart Association grants to study ways to treat heart failure through cellular repair. In 2021, he received the Association's Clinical Research Prize for his groundbreaking work in minimally invasive heart valve repair. Earlier in his career, he received the Vivien Thomas Young Investigator Award (1997) for postdoctoral research on molecular strategies to reduce myocardial ischemic injury. Dr. Woo holds patents for several heart-related medical devices and surgical techniques and has co-authored over 490 peer-reviewed papers. Beyond his research, he is deeply committed to mentorship, global collaboration and advancing medical education in cardiovascular health. "As a physician-scientist, I have been a daily witness to the tragedy of cardiovascular disease on human life, and also to the triumph of improving health and saving lives through scientific discovery," Woo said. "The American Heart Association is a global leader in supporting vital research and establishing the best evidenced-based approaches to cardiovascular health and treatment grounded in basic science, engineering, translational and clinical investigation. I look forward to continuing to support the Association as we continue our bold endeavors toward a healthier world for all." "We are honored to welcome Dr. Jen Ashton and Dr. Joe Woo to our Board of Directors," said Nancy Brown, CEO of the American Heart Association. "Dr. Ashton's national media profile, influence and dedication to preventive health, alongside Dr. Woo's groundbreaking work in cardiovascular surgery and academic leadership, uniquely position them to help us change the future of health and drive forward our mission. Their perspectives will be instrumental as we continue our work to bring health and hope to everyone, everywhere." These appointments reflect the American Heart Association's continued commitment to science-based solutions, community-centered approaches and bold leadership in the fight against heart disease and stroke. The American Heart Association's Board of Directors is the organization's top volunteer governing body, working closely with CEO Nancy Brown to provide strategic oversight and financial stewardship to advance the organization's mission of longer, healthier lives for all. Board members also serve as ambassadors, leveraging their individual professional expertise and networks of influence to further extend, accelerate and elevate the Association's visibility, impact and collaborations. Additional Resources Multimedia is available on the right column of release link. Learn more about the American Heart Association's 2025-26 volunteer and staff leadership. Follow AHA/ASA news on X @HeartNews ### About the American Heart Association The American Heart Association is a relentless force for a world of longer, healthier lives. Dedicated to ensuring equitable health in all communities, the organization has been a leading source of health information for more than one hundred years. Supported by more than 35 million volunteers globally, we fund groundbreaking research, advocate for the public's health, and provide critical resources to save and improve lives affected by cardiovascular disease and stroke. By driving breakthroughs and implementing proven solutions in science, policy, and care, we work tirelessly to advance health and transform lives every day. Connect with us on Facebook, X or by calling 1-800-AHA-USA1. For Media Inquiries and AHA/ASA Expert Perspective: 214-706-1173 Suzanne Grant: For Public Inquiries: 1-800-AHA-USA1 (242-8721) and Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Associated Press
16-07-2025
- Health
- Associated Press
Dr. Jennifer Ashton and Dr. Joseph Woo join American Heart Association Board of Directors
( NewMediaWire ) - July 16, 2025 - DALLAS — The American Heart Association, the world's leading nonprofit organization focused on heart and brain health for all, announces the appointment of two leading health and science leaders, Jennifer Ashton, M.D., M.S. and Joseph Woo, M.D., FAHA, to its volunteer Board of Directors, effective July 1, 2025. Dr. Ashton and Dr. Woo bring clinical leadership, health media influence and scientific innovation to the Association as it enters its second century, intensifying its efforts to change the future of health and improve cardiovascular and cerebrovascular health outcomes, which continue to be leading causes of death in the United States. Double board-certified in Ob-Gyn and obesity medicine, Dr. Jennifer Ashton is a nationally recognized women's health advocate known for communicating complex medical topics in an accessible way. As ABC News' Chief Medical Correspondent, she became a nationally trusted voice during major public health events, including the COVID-19 pandemic. A Columbia duPont and Emmy Award-winning journalist, a bestselling author and champion of preventive health and mental wellness, Dr. Ashton has volunteered with the American Heart Association for more than a decade, frequently speaking at local Go Red for Women(R) events. She has received numerous honors from the Association, including the 2024 Heart Saver Hero Award, the 2023 ' Woman Changing the World Award ' and the Go Red for Women Award in 2018. These accolades reflect her tireless advocacy for women's cardiovascular health and her leadership in advancing the Association's mission through education and action. 'As the obesity and maternal mortality epidemics are two of the most pressing issues affecting women in the U.S., and since both have cardiovascular associations, I hope that my experience and expertise in these fields can assist the American Heart Association's efforts,' Ashton said. 'And, as the daughter of a cardiologist, I am honored to be the first OB-GYN appointed to the Board in the history of the Association.' As a board-certified cardiothoracic surgeon, cardiovascular surgeon and transplant surgeon, Dr. Joseph Woo is a nationally recognized leader and educator in cardiac surgery innovation. He is professor and chair of the Stanford Medicine Department of Cardiothoracic Surgery, associate director of the Stanford Cardiovascular Institute and the Norman E. Shumway Professor of Cardiothoracic Surgery. He has pioneered advanced surgical research on multiple studies and clinical trials, including numerous National Institutes of Health (NIH) grant projects, as well as American Heart Association grants to study ways to treat heart failure through cellular repair. In 2021, he received the Association's Clinical Research Prize for his groundbreaking work in minimally invasive heart valve repair. Earlier in his career, he received the Vivien Thomas Young Investigator Award (1997) for postdoctoral research on molecular strategies to reduce myocardial ischemic injury. Dr. Woo holds patents for several heart-related medical devices and surgical techniques and has co-authored over 490 peer-reviewed papers. Beyond his research, he is deeply committed to mentorship, global collaboration and advancing medical education in cardiovascular health. 'As a physician-scientist, I have been a daily witness to the tragedy of cardiovascular disease on human life, and also to the triumph of improving health and saving lives through scientific discovery,' Woo said. 'The American Heart Association is a global leader in supporting vital research and establishing the best evidenced-based approaches to cardiovascular health and treatment grounded in basic science, engineering, translational and clinical investigation. I look forward to continuing to support the Association as we continue our bold endeavors toward a healthier world for all.' 'We are honored to welcome Dr. Jen Ashton and Dr. Joe Woo to our Board of Directors,' said Nancy Brown, CEO of the American Heart Association. 'Dr. Ashton's national media profile, influence and dedication to preventive health, alongside Dr. Woo's groundbreaking work in cardiovascular surgery and academic leadership, uniquely position them to help us change the future of health and drive forward our mission. Their perspectives will be instrumental as we continue our work to bring health and hope to everyone, everywhere.' These appointments reflect the American Heart Association's continued commitment to science-based solutions, community-centered approaches and bold leadership in the fight against heart disease and stroke. The American Heart Association's Board of Directors is the organization's top volunteer governing body, working closely with CEO Nancy Brown to provide strategic oversight and financial stewardship to advance the organization's mission of longer, healthier lives for all. Board members also serve as ambassadors, leveraging their individual professional expertise and networks of influence to further extend, accelerate and elevate the Association's visibility, impact and collaborations. Additional Resources ### About the American Heart Association The American Heart Association is a relentless force for a world of longer, healthier lives. Dedicated to ensuring equitable health in all communities, the organization has been a leading source of health information for more than one hundred years. Supported by more than 35 million volunteers globally, we fund groundbreaking research, advocate for the public's health, and provide critical resources to save and improve lives affected by cardiovascular disease and stroke. By driving breakthroughs and implementing proven solutions in science, policy, and care, we work tirelessly to advance health and transform lives every day. Connect with us on Facebook, X or by calling 1-800-AHA-USA1. For Media Inquiries and AHA/ASA Expert Perspective: 214-706-1173 Suzanne Grant: [email protected] For Public Inquiries: 1-800-AHA-USA1 (242-8721) and
Business Wire
24-06-2025
- Health
- Business Wire
Results From the World's First Observational Study of ExoStat Medical's MicroTREND System Support P OM CO 2 as an Important Early Indicator of Septic Shock in Critically Ill Patients
PRIOR LAKE, Minn.--(BUSINESS WIRE)--ExoStat Medical, Inc. a medical device company engaged in the research and development of the novel MicroTREND System which non-invasively monitors microcirculatory tissue perfusion in real-time at the bedside announced today the successful completion of the world's first IRB-approved, ICU observational septic shock study to assess the efficacy and clinical utility of oral mucosal partial pressure CO 2 (P om CO 2) as a parameter for determining the status of microcirculatory tissue perfusion. The findings of this study concluded that data produced by the MicroTREND could, as an adjunct tool, enhance the value of data currently gathered by macrohemodynamic tools currently considered standard protocol. "This first-ever study marks a major milestone for critical care and for ExoStat,' said Wanchun Tang, MD, MCCM, FAHA, FNAI. Share Conducted at the Second Affiliated Hospital of Anhui Medical University (Hefei, China) the study enrolled 23 septic shock patients and assessed the role of bedside oral mucosa tissue monitoring P om CO 2 as an indicator of early septic shock dysfunction. The study completed a comparative analysis of current standards of care including serum lactate, now considered the gold standard for tissue perfusion evaluation. Principal Investigators of the study are currently preparing the results for near-future publication. 'This first-ever study marks a major milestone for critical care, for ExoStat, and for me as it has been a 40-year project that started with the Weil Institute in the 1980's,' said Wanchun Tang, MD, MCCM, FAHA, FNAI, and Senior Technology and Medical Advisor for ExoStat. 'For the first time ever, physicians were able to view, in real time, the very early and ongoing signs of microcirculatory dysfunction due to tissue hypoperfusion. Every moment matters in septic shock and delays can be devastating to the patient. This device can produce actuals that can provide the physician with more reaction time. It is now well-understood that the current macrohemodynamic tools do not fully capture real-time metrics of the patient under care. This study finally brought what was hypothesis into reality. It was exciting to observe.' Dr. Tang later admitted that it was difficult to see the first measures on the monitor due to tears of joy. The MicroTREND is a patented, FDA-cleared non-invasive monitoring system that detects P om CO 2 using a microsensor that sits atop the inner cheek buccal tissue. There are no needles, no blood, no catheters, and no 'lag in time' for lab work required. The importance of time cannot be overstated in treating all shock states, especially sepsis. All shock cases begin with tissue hypoperfusion. It is a common denominator. 'This study achieved the ultimate objective of ExoStat's mission which was to provide microcirculatory perfusion awareness to physicians who treat the sickest of the sick', stated Jim Hays, Chief Executive Officer of ExoStat. 'We are excited to embark now on our second phase of pre-market clinical testing being planned with iconic research institutions where we will focus on achieving a better understanding of the effect of current standards of care on microcirculation. These are exciting times indeed.' About ExoStat Medical ExoStat Medical Inc. is a privately-held medical device company located in Prior Lake, MN. The research and development quest to create the MicroTREND began in 2008 as a vision of Max Harry Weil, MD, who is often called 'the father of critical care medicine'. The technology platform developed by ExoStat provides data to enable physicians to assess and to treat microcirculatory hypoperfusion, a life-threatening medical emergency. Visit for more information.
